Immunohematology Market Size, Share and Trends 2026 to 2035

Revenue, 2025

USD 2.86 Bn

Forecast Year, 2035

USD 4.21 Bn

CAGR, 2026 - 2035

3.94%

Report Coverage

Global

What is the Immunohematology Market Size?

The global immunohematology market size was exhibited at USD 2.86 billion in 2025 and is predicted to increase from USD 2.98 billion in 2026 to approximately USD 4.21 billion by 2035, expanding at a CAGR of 3.94% from 2026 to 2035. The immunohematology market is driven by the growing prevalence of blood diseases, rising demand for transfusions, and advances in diagnostic technologies.

Immunohematology Market Key Takeaways

• In terms of revenue, the global immunohematology market was valued at USD 2.86 billion in 2025.
• It is projected to reach USD 4.21 billion by 2035.
• The market is expected to grow at a CAGR of 3.94% from 2026 to 2035.
• North America dominated the market with the largest revenue share of 39% in 2025.
• By product, the reagents segment has contributed more than 66% of revenue share in 2025.
• By technology, the PCR segment has held the largest revenue share of 39% in 2025.
• By end use, the diagnostic laboratories segment has captured the biggest revenue share of 25% in 2025.

Market Overview

Immunohematology is a specialized branch of laboratory medicine that encompasses the study of blood and blood transfusion and transplantation, blood groups, antigens, and antibodies. The immunohematology market is categorized into products such as diagnostic instruments, diagnostic reagents, blood typing systems, and biochemical-based techniques for safe and compatible transfusion of blood. The rising frequency of blood donation, increasing awareness regarding transfusion safety, and the growing number of surgical procedures are propelling the market. Furthermore, growing healthcare expenditure, organ transplants, and the need for high accuracy in immunologic compatibility testing are contributing to the market expansion.

Artificial Intelligence: The Next Growth Catalyst in the Immunohematology Industry

AI is transforming the immunohematology industry by enhancing precision, speed, and safety in blood testing. AI-driven blood analyser AI algorithms and machine learning models are now used to automate antibody screening, identify blood types, and interpret complex gel card images, reducing human error and boosting lab throughput. AI supports patient blood management by analysing patient history to optimize transfusion strategies and predict adverse transfusion reactions in real-time.

Immunohematology Market Growth Factors

• The continuous need for blood transfusions, particularly for patients with blood cancers, drives the market growth. With thousands of blood components being transfused daily, the reliance on volunteer blood donors becomes crucial for ensuring a steady supply, thus contributing to market expansion.
• As the population ages and medical practices become more sophisticated, the demand for blood component therapy is expected to increase. This demographic trend, coupled with advancements in medical treatments, acts as a growth factor for the market.
• Extensive awareness programs aimed at educating, motivating, and recruiting blood donors play a pivotal role in ensuring an adequate supply of safe blood. Launching such initiatives leads to market growth by fostering a culture of regular blood donation.
• Recognizing the importance of safe and adequate blood supply, countries are increasingly integrating blood transfusion services into their national healthcare policies and infrastructure. This strategic approach contributes to market growth by prioritizing the availability of blood as an essential healthcare component.
• Emphasizing the collection of blood, plasma, and other components from low-risk, voluntary unpaid donors through strengthened donation systems and effective donor management fosters market growth by ensuring a sustainable and reliable blood supply chain.
• Promoting the rational use of blood and blood products, along with implementing safe and good clinical transfusion practices, including patient blood management, reduces unnecessary transfusions and associated risks. This focus on efficiency and safety drives market growth by instilling confidence in blood transfusion services.
• Addressing concerns about transfusion-transmitted diseases requires the adoption of advanced technology for blood screening, voluntary donations, donor selection, and maintaining aseptic conditions during transfusion. Investing in these technological advancements is essential for market growth as it enhances safety and reduces transmission risks.

Immunohematology Market Trends

• Growing Ageing Population and Advanced Medical Treatments

The demand for blood component therapy will continue to grow due to high blood demand among the elderly and high throughput of the blood transfusion practice. With an increasing elderly population and advanced surgical/treatment procedures, the blood demand will increase, leading to blood component therapy.

• Increasing Blood Donation Awareness Programs

The Government and health organizations are promoting blood donation awareness among the people in favor of free blood donation to have enough blood in hospitals and a good infrastructure of transfusion medicine.

• Integration of Blood Services into Healthcare Systems

Blood transfusion services have progressively been adopted into the national health systems of the countries, aiming for the availability, safety, and access to blood for critical care and emergencies.

• Technological Advancements in Blood Screening

Advanced screening and molecular diagnostic technologies and the use of automated testing systems aid in safer transfusion practices, reducing the risk of disease transmission, while enhancing efficiency in immunohematology practice.

Market Outlook

• Market Growth Overview: The Immunohematology market is expected to grow significantly between 2025 and 2034, driven by the rising demand for blood transfusion services, focus on blood safety and quality control, and expansion of healthcare infrastructure.
• Sustainability Trends: Sustainability trends involve eco-friendly packaging and waste reduction, smart resource management, and automation and digitalization.
• Major Investors: Major investors in the market include Bio-Rad Laboratories, Inc., QuidelOrtho Corporation, Grifols S.A., Immucor, Inc., and Abbott Laboratories.

Market Scope

Immunohematology Market Dynamics

Drivers

Meeting clinical demand through enhanced safety and efficiency

The immunohematology market experiences growth as the demand for blood transfusion, though showing a decreasing trend due to heightened awareness and adherence to patient blood management principles, underscores the need for timely access to safe blood in healthcare facilities. This shift in demand highlights the importance of efficient blood transfusion services, driving the necessity for advanced immunohematology solutions that ensure safe preparation, selection, and monitoring of blood components, ultimately aligning with evolving clinical needs and fostering market expansion through innovation and enhanced patient outcomes.

Advancements in transfusion medicine and quality assurance

The evolution of the blood transfusion system, propelled by advancements in Transfusion Medicine and Technology, underscores its pivotal role within healthcare services. Measures to ensure the quality of blood and its products have become imperative, driving the need for enhanced standards in blood banks and transfusion services. The National AIDS Control Organization, through the Technical Resource Group on Blood Safety, has played a significant role in formulating comprehensive standards to elevate the quality control system encompassing collection, storage, testing, and distribution of blood and its components. These efforts not only enhance patient safety but also contribute to the growth of the immunohematology market by fostering a culture of excellence and innovation within the field.

Restraint

High Initial Investment

The adoption of automation in immunohematology poses a significant financial barrier due to its expensive nature, typically requiring substantial initial investments. While some facilities may opt for a 'reagent rental agreement' to mitigate costs, this model still entails ongoing expenses for reagents and maintenance. Moreover, the initial costing includes not only the equipment but also expenses for room restructuring, reagent storage facilities, and interfacing hardware and software with the hospital information system (HIS). Additionally, the variability in testing costs, influenced by the type of testing and individual center protocols, makes cost comparison challenging. Despite the potential efficiency gains, the high upfront and operational costs associated with automation limit the growth of the immunohematology market.

Opportunities

Advancements in Testing Technologies

The introduction of advanced testing technologies, such as microcolumns and polystyrene microplates, presents significant opportunities for growth within the immunohematology market. These innovations offer distinct advantages, including the ability to conduct antiglobulin tests without washing steps and enhanced visualization of reactions. Moreover, the development of more recent systems utilizing microplates sensitized by human antiglobulin allows for visualizing reactions through magnetized red cells, further streamlining testing processes. By combining these techniques with the latest generation of automated instruments, healthcare facilities can achieve greater efficiency and accuracy in immunohematology testing. These advancements not only enable the resolution of complex cases but also open doors for expanding the scope of immunohematology services. With the potential to enhance patient care and diagnostic capabilities, the adoption of these sophisticated technologies represents a promising opportunity for growth within the immunohematology market.

Advancements in Diagnostic Methods

The continuous evolution of diagnostic methods for in vitro measurements of the antigen-antibody reaction presents significant opportunities within the immunohematology market. Important innovations have led to substantial improvements in blood compatibility between donors and recipients, enhancing patient safety and transfusion outcomes. The utilization of completely automated systems, coupled with information technology integration, emerges as a highly efficient strategy. By automating various stages, including sample identification, reagent selection, result interpretation, and data transfer to laboratory information management systems, these systems significantly reduce transfusion risks associated with human errors. This integration not only enhances workflow efficiency but also improves overall laboratory performance, creating promising opportunities for growth and advancement within the immunohematology market.

Segtment Insights

Product Insights

The Reagents Segment Dominated the Immunohematology Market in 2025

The reagents segment dominated the market by holding the largest share in 2025 because of their essential role in blood typing, antibody screening, and compatibility testing procedures. Reagents are critical laboratory tools used to identify blood group antigens and antibodies, enabling healthcare professionals to ensure safe blood transfusions, support organ transplantation procedures, and diagnose various hematological conditions. Their widespread and routine use across hospitals, blood banks, and diagnostic laboratories has contributed significantly to the segment's market leadership.

The analyzers segment is expected to witness significant growth during the forecast period, driven by the increasing demand for rapid and accurate diagnostic testing and the growing adoption of laboratory automation. Immunohematology analyzers enhance testing efficiency by reducing manual intervention, minimizing errors, and improving the accuracy of blood typing and antibody detection processes. Furthermore, rising investments in advanced diagnostic technologies, coupled with ongoing improvements in healthcare infrastructure and laboratory capabilities, are expected to accelerate the adoption of automated immunohematology analyzers.

Technology Insights

Why Did the PCR Segment Led the Immunohematology Market in 2025

The PCR segment led the market in 2025 with the largest share due to its high accuracy in blood typing and its ability to overcome limitations of traditional serological methods. PCR-based molecular diagnostic techniques enable precise identification of blood group antigens and improve compatibility testing, reducing the risk of transfusion errors. The PCR technology is also gaining further traction as demand for advanced molecular diagnostics and highly accurate blood compatibility testing continues to grow.

The erythrocyte-magnetized technology segment is expected to grow rapidly during the forecast period due to increasing demand for faster blood sample processing and higher levels of automation in laboratories. This technology eliminates the need for centrifugation and can be integrated into fully automated blood typing systems, improving efficiency and workflow in diagnostic labs and hospitals. Additionally, rising emphasis on transfusion safety and reducing human errors is driving adoption across immunohematology applications.

The gel cards segment is projected to grow at a steady rate in the coming years due to its widespread use in blood grouping, antibody screening, and cross-matching procedures. Gel card technology offers higher accuracy and standardization and eliminates the need for manual interpretation, making it a preferred choice in many diagnostic settings. Growing focus on transfusion safety and the need for reliable, standardized testing methods continue to support its adoption.

The biochips segment is expected to grow at a notable rate over the projection period due to advancements in molecular diagnostics and the increasing shift toward personalized medicine. Biochip technology enables high-throughput screening, rapid testing, and simultaneous detection of multiple blood group markers, improving diagnostic efficiency and precision. Rising demand for precision healthcare solutions and continuous innovation in diagnostic technologies are further driving growth in this segment

End Use Insights

What Made Diagnostic Laboratories the Dominant Segment in the Immunohematology Market?

The diagnostic laboratories segment dominated the immunohematology market in 2025 due to the growing adoption of advanced diagnostic technologies and the rising preference for centralized testing services. These laboratories utilize automated analyzers, sensitive platforms, and specialized reagents to perform accurate blood typing and antibody screening. Healthcare providers increasingly rely on centralized diagnostic labs to ensure standardized, reliable, and high-precision immunohematology testing across patient populations.

The hospitals segment is expected to grow at a significant rate during the forecast period, driven by rising hospital admissions, an increasing number of surgical procedures, and higher demand for emergency blood transfusions, particularly in trauma and critical care cases. Strict regulatory standards and quality control requirements in hospitals further emphasize the need for accurate and timely immunohematology testing to ensure patient safety. Additionally, the growing burden of chronic diseases and increasing organ transplantation procedures are further boosting demand for blood compatibility testing in hospital settings.

The blood banks segment is projected to grow rapidly due to increasing blood donation activities and expanding blood banking infrastructure worldwide. Blood banks play a crucial role in the collection, storage, compatibility testing, and distribution of blood for both emergency and planned medical procedures. Rising voluntary blood donations, along with government initiatives aimed at strengthening blood supply systems, are driving the need for advanced immunohematology testing solutions to ensure safe and efficient blood management.

Regional Insights

What is the U.S. Immunohematology Market Size?

The U.S. immunohematology market size was estimated at USD 780 million in 2025 and is predicted to be worth around USD 1,210 million by 2035, with a CAGR of 4.49% from 2026 to 2035.

What Made North America the Dominant Region in the Immunohematology Market?

North America dominated the immunohematology market with the largest share in 2025 due to its advanced healthcare infrastructure, high adoption of automated diagnostic technologies, and strong demand for blood transfusion services. The region benefits from well-established blood banking systems, favorable reimbursement policies, and increasing prevalence of chronic diseases that require frequent transfusions. Continuous investments in molecular diagnostics, blood safety solutions, and immunohematology analyzers are further strengthening market growth across the region.

U.S. Market Trends

The U.S. represents the largest market within North America, driven by high utilization of blood transfusion services and rising incidence of transfusion-dependent conditions. Growing demand for precise blood compatibility testing, organ transplantation procedures, and advanced molecular diagnostic techniques is fueling market expansion. In addition, increasing automation in laboratory systems is improving efficiency and safety, while sustained healthcare investments are expanding access to advanced immunohematology testing.

Why is Asia Pacific Undergoing the Fastest Growth in the Immunohematology Market?

Asia Pacific is expected to witness the fastest growth during the forecast period, supported by rising healthcare expenditure, expanding healthcare infrastructure, and increasing demand for blood transfusion services. A large and growing population, along with a higher burden of chronic diseases, is driving the need for reliable blood typing and compatibility testing. Government initiatives promoting voluntary blood donation and strengthening healthcare systems are further accelerating regional market development.

China Market Trends

China's immunohematology market is projected to grow significantly due to rising awareness of transfusion safety, increasing healthcare spending, and rapid expansion of healthcare infrastructure. The growing prevalence of chronic diseases and rising number of surgical procedures are boosting demand for blood typing and compatibility testing services. Additionally, government support for healthcare modernization and blood donation programs is further driving market growth in the country.

How is the Opportunistic Rise of Europe in the Immunohematology Market?

Europe is expected to grow at a significant rate during the forecast period due to high healthcare expenditure, a rapidly aging population, and the rising prevalence of chronic diseases. The region benefits from well-established healthcare systems and frequent blood transfusion activities, which enhance the demand for safe and efficient blood management. Growth is further supported by the increasing adoption of molecular diagnostics, automation in blood typing, and standardized transfusion practices across healthcare facilities.

Germany Market Trends

Germany's immunohematology market is projected to grow steadily, supported by advanced healthcare infrastructure, a strong regulatory framework, and rising demand for transfusion-related diagnostics. The country's aging population and increasing number of complex surgical procedures are driving the need for accurate blood compatibility testing. In addition, the adoption of laboratory automation and advanced molecular diagnostic technologies is improving testing accuracy, efficiency, and overall clinical outcomes.

What are the Key Trends in the Immunohematology Market in Latin America?

The immunohematology market in Latin America is expanding due to improvements in healthcare infrastructure and growing awareness of the importance of blood donation. Rising cases of chronic diseases and trauma-related emergencies are increasing the demand for blood screening and compatibility testing services. Government bodies and healthcare organizations are also investing in strengthening blood banking systems and laboratory capabilities across the region.

Brazil Market Trends

Brazil's immunohematology market is expected to grow due to increasing healthcare investments, rising surgical procedures, and expanding blood donation programs. Greater awareness of transfusion safety and improvements in healthcare infrastructure are supporting the adoption of advanced blood typing and screening technologies. Additionally, the growing burden of chronic diseases and government efforts to improve healthcare access are further driving market expansion.

What Drives the Middle East & Africa Immunohematology Market?

The Middle East & Africa immunohematology market is driven by improving healthcare infrastructure, rising healthcare expenditure, and increasing awareness of blood safety. Demand for immunohematology testing is growing due to the rising incidence of chronic diseases and trauma cases requiring transfusions. Government initiatives aimed at modernizing healthcare systems and strengthening blood donation programs are also supporting market development.

Saudi Arabia Market Trends

Saudi Arabia's immunohematology market is expected to grow steadily due to ongoing healthcare reforms, increasing healthcare spending, and enhanced focus on transfusion safety. Rising surgical procedures and the growing prevalence of chronic diseases are increasing demand for blood compatibility testing. Additionally, government-led initiatives to modernize healthcare infrastructure and improve laboratory systems are further contributing to market growth.

Value Chain Analysis of the Immunohematology Market

• Research & Development (R&D) and Component Sourcing
  This foundational stage focuses on developing monoclonal reagents, innovative gel card technologies, and AI-driven software for blood typing, antibody screening, and molecular genotyping.
  Key Players: Bio-Rad Laboratories, Inc., Immucor Inc., Grifols S.A., Thermo Fisher Scientific Inc., Ortho Clinical Diagnostics, and Quotient Limited.
• Manufacturing and Production
  Manufacturing involves the high-volume production of automated analyzers, specialized reagents, antisera, and consumable gel cards under stringent regulatory standards (FDA/EMA).
  Key Players: Grifols S.A., Immucor Inc., Bio-Rad Laboratories, QuidelOrtho, and Beckman Coulter.
• Distribution and Logistics
  This stage requires a robust global supply chain, often involving direct sales to large hospitals and third-party distributors to reach smaller clinics and laboratories, particularly in emerging markets.
  Key Players: Cardinal Health Inc., Thermo Fisher Scientific, McKesson Corporation.

Competitive Landscape

The immunohematology market is highly competitive and moderately consolidated, with leading global players focusing on innovation, automation, and expansion of advanced diagnostic portfolios. Key companies such as Abbott Laboratories, Bio-Rad Laboratories, Grifols, and Thermo Fisher Scientific are strengthening their positions through continuous R&D investments in molecular diagnostics, blood typing systems, and automated analyzers. These companies compete on technological advancement, product accuracy, workflow efficiency, and integrated laboratory solutions, while also expanding their global distribution networks and strategic partnerships with hospitals and blood banks.

Competition is also intensifying due to the entry of specialized diagnostic and biotechnology firms that are introducing niche innovations in antibody screening, reagents, and next-generation blood typing technologies. Market players are increasingly adopting strategies such as mergers and acquisitions, collaborations, and product launches to enhance their portfolios and geographic reach.

Immunohematology Market Companies

• Grifols S.A.: Grifols provides automated analyzers and a comprehensive range of reagents, such as DG Gel cards, to facilitate rapid, accurate blood typing and antibody screening in transfusion medicine.
• Immucor Inc.: Immucor delivers specialized instruments and serology-based reagents, including its patented Capture solid-phase technology, to ensure safe donor-recipient compatibility testing.
• Thermo Fisher Scientific: Thermo Fisher offers a broad range of high-quality tools, including reagents, consumables, and advanced imaging systems, used for blood typing, cross-matching, and antibody identification.
• Merck KGaA: Merck KGaA supplies high-quality reagents and specialized laboratory tools that are critical for blood group serology and immunohematology research.
• Abbott Laboratories: Abbott Laboratories develops advanced diagnostic platforms and automated systems that enable precise, rapid, and high-throughput blood screening for transfusion safety.

Recent Developments

• In January 2026, the FDA expanded the use of Sanofi's Cablivi (caplacizumab-yhdp) for pediatric (ages 12 years and older) acquired thrombotic thrombocytopenic purpura (aTTP). This licence offers additional treatment options for youth with rare blood disorders for which targeted therapy could be employed, and is complementary to the treatment options that are available for immunohematology therapy.
• In June 2025, the government of Kerala launched software to monitor blood banks and enhance the management of blood supply in the state. Actually, the platform offers live blood availability and blood storage details to optimise blood transfusion services and boost accessibility.
• In February 2026, QuidelOrtho entered a strategic supply agreement with Lifotronic Technology to expand its global immunoassay portfolio with over 25 new assays, targeting international markets outside the US. This partnership aims to enhance competitiveness by providing scalable high-throughput and low-to-mid volume analysers, bridging menu gaps for diverse laboratory needs. https://www.medicaldevice-network.com

Segments Covered in the Report

By Product

• Analyzers
• Reagents

By Technology

• Biochips
• Gel Cards
• Microplates
• PCR
• Erythrocyte-Magnetized Technology

By End-User

• Hospitals
• Diagnostic Laboratories
• Blood banks

By Geography

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East & Africa